Upgrade to SI Premium - Free Trial

Diagnos, Inc. (DGNOF)

0.35 +0.03 (9.37%)

Chart
Today 6M 1Y 5Y

Latest Headlines

DIAGNOS to Hold its Annual General Meeting of Shareholders on September 30, 2026 September 14, 2026 12:41 PM - Globe NewsWire DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI-Assisted Retinal Image Analysis to Saudi Arabia August 13, 2026 2:21 PM - Globe NewsWire DIAGNOS Receives Health Canada Medical Device Licence for CARA System, Bringing AI-Assisted Retinal Image Analysis to Canadian Optometrists July 27, 2026 3:20 PM - Globe NewsWire Presenting on Emerging Growth Conference 94 Day 1 on July 15; Register to live stream July 14, 2026 7:00 AM - Globe NewsWire DIAGNOS to Extend the Exercise Period of Stock Warrants July 7, 2026 12:38 PM - Globe NewsWire DIAGNOS Announces Shares for Debt Settlement June 18, 2026 12:00 PM - Globe NewsWire DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform June 16, 2026 9:15 AM - Globe NewsWire Full Article List